Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 2.   Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids
  2. Seiple, L. A.; Cardellina, J. H.; Akee, R.; Stivers, J. T.
  3. Molecular Pharmacology. 2008 73(3): 669-677.
  1. 3.   Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells
  2. Brantley, E.; Antony, S.; Kohlhagen, G.; Meng, L. H.; Agama, K.; Stinson, S. F.; Sausville, E. A.; Pommier, Y.
  3. Cancer Chemotherapy and Pharmacology. 2006, Jul; 58(1): 62-72.
  1. 4.   Long homopurine center dot homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region
  2. Bacolla, A.; Collins, J. R.; Gold, B.; Chuzhanova, N.; Yi, M.; Stephens, R. M.; Stefanov, S.; Olsh, A.; Jakupciak, J. P.; Dean, M.; Lempicki, R. A.; Cooper, D. N.; Wells, R. D.
  3. Nucleic Acids Research. 2006 34(9): 2663-2675.
  1. 5.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 6.   Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells
  2. Pengt, B.; Hodge, D. R.; Thomas, S. B.; Cherry, J. M.; Munroe, D. J.; Pompeia, C.; Xiao, W. H.; Farrar, W. L.
  3. Journal of Biological Chemistry. 2005, FEB 11; 280(6): 4182-4187.
  1. 7.   Intra- and intercellular variations in the repair efficiency of O-6-methylguanine, and their contribution to kinetic complexity
  2. Souliotis, V. L.; Sfikakis, P. P.; Anderson, L. M.; Kyrtopoulos, S. A.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2004, DEC 21; 568(2): 155-170.
  1. 8.   The Rad27 (Fen-1) nuclease inhibits Ty1 mobility in Saccharomyces cerevisiae
  2. Sundararajan, A.; Lee, B. S.; Garfinkel, D. J.
  3. Genetics. 2003 163(1): 55-67.
  1. 9.   Enhancement of platinum-induced cytotoxicity by O-6- Benzylguanine
  2. Fishel, M. L.; Delaney, S. M.; Friesen, L. D.; Hansen, R. J.; Zuhowski, E. G.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Molecular Cancer Therapeutics. 2003 2(7): 633-640.
  1. 10.   Error-prone DNA polymerases: When making a mistake is the only way to get ahead
  2. Rattray, A. J.; Strathern, J. N.
  3. Annual Review of Genetics. 2003 37: 31-66.
  1. 11.   The roles of REV3 and RAD57 in double-strand-break-repair- induced mutagenesis of Saccharomyces cerevisiae
  2. Rattray, A. J.; Shafer, B. K.; McGill, C. B.; Strathern, J. N.
  3. Genetics. 2002 162(3): 1063-1077.
  1. 12.   The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
  2. Khan, S. G.; Muniz-Medina, V.; Shahlavi, T.; Baker, C. C.; Inui, H.; Ueda, T.; Emmert, S.; Schneider, T. D.; Kraemer, K. H.
  3. Nucleic Acids Research. 2002 30(16): 3624-3631.
  1. 13.   DNA repair protein levels vis-a-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program
  2. Xu, Z. Y.; Chen, Z. P.; Malapetsa, A.; Alaoui-Jamali, M.; Bergeron, J.; Monks, A.; Myers, T. G.; Mohr, G.; Sausville, E. A.; Scudiero, D. A.; Aloyz, R.; Panasci, L. C.
  3. Anti-Cancer Drugs. 2002 13(5): 511-519.
  1. 14.   Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency
  2. Hollander, M. C.; Kovalsky, O.; Salvador, J. M.; Kim, K. E.; Patterson, A. D.; Raines, D. C.; Fornace, A. J.
  3. Cancer Research. 2001 61(6): 2487-2491.
  1. 15.   Fidelity of mitotic double-strand-break repair in Saccharomyces cerevisiae: A role for SAE2/COM1
  2. Rattray, A. J.; McGill, C. B.; Shafer, B. K.; Strathern, J. N.
  3. Genetics. 2001 158(1): 109-122.
  1. 16.   The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms
  2. Emmert, S.; Schneider, T. D.; Khan, S. G.; Kraemer, K. H.
  3. Nucleic Acids Research. 2001 29(7): 1443-1452.
  1. 17.   The Saccharomyces cerevisiae DNA recombination and repair functions of the RAD52 epistasis group inhibit Tyl transposition
  2. Rattray, A. J.; Shafer, B. K.; Garfinkel, D. J.
  3. Genetics. 2000 154(2): 543-556.
  1. 18.   A Role For Rev3 in Mutagenesis During Double-Strand Break Repair in Saccharomyces Cerevisiae
  2. Holbeck, S. L.; Strathern, J. N.
  3. Genetics. 1997 147(3): 1017-1024.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel